Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CLL Variant”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Looking for participantsNCT06978088
What this trial is testing

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaSmall Lymphocytic LymphomaCLL/SLL+1 more
Zulfa Omer 34
Testing effectiveness (Phase 2)Looking for participantsNCT07014917
What this trial is testing

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL Variant
Zulfa Omer 62
Testing effectiveness (Phase 2)Looking for participantsNCT07108998
What this trial is testing

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

Who this might be right for
CLL/SLLCLLSLL+4 more
Zulfa Omer 22
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Early research (Phase 1)Study completedNCT00060684
What this trial is testing

Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-GradeLymphoma, Small LymphocyticLymphoma, Mixed-Cell, Follicular+1 more
CTI BioPharma 30
Not applicableNot Yet RecruitingNCT07463976
What this trial is testing

VariaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway

Who this might be right for
Chronic Lymphocytic LeukemiaHaematological Malignancy
The Royal Wolverhampton Hospitals NHS Trust 130
Testing effectiveness (Phase 2)Study completedNCT02869633
What this trial is testing

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Who this might be right for
Blastoid Variant Mantle Cell LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Follicular Lymphoma+6 more
Vanderbilt-Ingram Cancer Center 23